Source 1review2026MED
Toolkit/LMP1-directed CAR recognition strategy
LMP1-directed CAR recognition strategy
Also known as: LMP1
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Explicitly named in the anchor review as an EBV CAR target. Foundational EBV latent antigen target for early proof-of-concept CAR studies.
Usefulness & Problems
Why this is useful
This strategy uses EBV LMP1 as the target antigen for CAR-T recognition.; building EBV-targeted CAR recognition modules; targeting LMP1 in EBV-associated CAR-T strategies
Source:
This strategy uses EBV LMP1 as the target antigen for CAR-T recognition.
Source:
building EBV-targeted CAR recognition modules
Source:
targeting LMP1 in EBV-associated CAR-T strategies
Problem solved
It provides an alternative EBV-directed targeting strategy for CAR-T engineering.; provides a named EBV target for CAR design
Source:
It provides an alternative EBV-directed targeting strategy for CAR-T engineering.
Source:
provides a named EBV target for CAR design
Problem links
provides a named EBV target for CAR design
LiteratureIt provides an alternative EBV-directed targeting strategy for CAR-T engineering.
Source:
It provides an alternative EBV-directed targeting strategy for CAR-T engineering.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
antigen-specific car recognitionTechniques
No technique tags yet.
Target processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenoperating role: actuator
It requires an LMP1-targeting recognition module incorporated into a CAR construct.; requires an LMP1-targeting recognition module in a CAR construct
The supplied evidence does not provide enough detail to compare it directly with gp350-targeted approaches.; the supplied payload does not provide exact primary proof-of-concept references or detailed review text
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The review explicitly names gp350 and LMP1 as EBV CAR target leads, and names BRG01 as a gp350-targeted autologous CAR-T product in clinical development.
The review explicitly names HBsAg-related and PreS1-related HBV CAR strategies, including 4D06 and 4D08 as HBV-directed binder leads.
The review explicitly names VRC01, 3BNC117, and 10-1074 as HIV broadly neutralizing antibody-derived CAR binder leads.
Within the supplied evidence, the strongest explicitly supported antiviral CAR design leads are HIV Env/bNAb-based CARs, HBV HBsAg-directed CARs, and EBV gp350/LMP1-directed CARs.
The review explicitly names CCR5-locus knock-in and C34-CXCR4 as HIV-protective engineering features relevant to antiviral CAR-T design.
Approval Evidence
1 source1 linked approval claimfirst-pass slug lmp1-directed-car-recognition-strategy
Explicitly named in the anchor review as an EBV CAR target. Foundational EBV latent antigen target for early proof-of-concept CAR studies.
Source:
component summarysupports
The review explicitly names gp350 and LMP1 as EBV CAR target leads, and names BRG01 as a gp350-targeted autologous CAR-T product in clinical development.
Source:
Comparisons
Source-stated alternatives
The payload explicitly names gp350 as another EBV CAR target.
Source:
The payload explicitly names gp350 as another EBV CAR target.
Source-backed strengths
explicitly named as an EBV CAR target in the supplied evidence
Source:
explicitly named as an EBV CAR target in the supplied evidence
Compared with gp350-directed CAR recognition strategy
The payload explicitly names gp350 as another EBV CAR target.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly named as an EBV CAR target in the supplied evidence.
Relative tradeoffs: the supplied payload does not provide exact primary proof-of-concept references or detailed review text.
Source:
The payload explicitly names gp350 as another EBV CAR target.
Ranked Citations
- 1.